Lowering Barriers to R&D Innovation
We are a global, not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in R&D.
Our projects transform R&D innovation through pre-competitive collaboration. We bring together the key constituents to identify the root causes that lead to R&D inefficiencies. We develop best practices and technology pilots to overcome common obstacles.
Our members collaborate as equals on open projects that generate significant value for the worldwide life sciences community.
With the launch of our Interactive Project Portfolio Platform (IP3) we are embracing a new level of openness, access, and transparency around our idea-to-project process. The platform is open to the public to submit new ideas, comment and vote on proposed ideas, and monitor the progress of our projects.
Let me say up front that we firmly believe as Barry does: That it’s through the ability to share key information services and facilitate effective collaboration that we ALL will increase our chances of successfully innovating. That’s what is going to bring success to our industry and to the future lives of patients everywhere.
A few weeks ago, Drug Discovery World published our article on obstacles to innovation in pharma, which was informed by a great conversation on this blog in May.
* A full list of our membership including individual members can be found here. (Last updated Jan 5 2018)